Alphavalue Morning Market Tip
Alphavalue Morning Market Tip
Another late-stage clinical trial setback for AstraZeneca.
Alphavalue Morning Market Tip
Average H1 26 results, Belron strategic review (IPO) and new CEO.
Alphavalue Morning Market Tip
Strong Q2 (May-July) and encouraging trading statement for August.
Alphavalue Morning Market Tip
Another setback in R&D could change the market's perception on Novartis.
Alphavalue Morning Market Tip
Feud at the top continues.
Alphavalue Morning Market Tip
Lackluster results with poor Gameloft performance - cautious stance reiterated.